Kneu Health
Kneu Health

Kneu Health

Reimagining care for dementia and Parkinson’s

Parkinson’s disease, dementia and other neurodegenerative conditions are fast becoming the biggest causes of mortality and morbidity worldwide. By 2050, 200m people are predicted to be living with these conditions.

Kneu Health enables clinicians, care givers and patients to tackle this growing challenge with cutting-edge digital technologies designed to make the latest care accessible for all, improving outcomes today and accelerating future breakthroughs.

Founded by OSE Entrepreneur-in-Residence Caroline Cake and Oxford neurologist Dr Kinan Muhammed, Kneu Health brings together validated clinical insight and digital innovation to tackle one of the most complex challenges in healthcare.

Sector
HealthTech
Stage
  • Pre-Seed/Seed
OSE Manager Limited, a wholly owned subsidiary of Oxford Science Enterprises plc, is authorised and regulated by the Financial Conduct Authority.